Research Article
Hydromorphone Protects against CO2 Pneumoperitoneum-Induced Lung Injury via Heme Oxygenase-1-Regulated Mitochondrial Dynamics
Table 1
Patient demographics and characteristics.
| | Index | Hydromorphone () | Morphine () | value |
| | Age (years) | | | 0.813 | | Weight (kg) | | | 0.145 | | BMI (kg/m2) | | | 0.258 | | Diagnosis, (%) | | | 0.863 | | Uterine myomas | 13 (52%) | 12 (48%) | | | Ovarian cysts | 9 (36%) | 37 (44%) | | | Endometrial carcinoma | 2 (8%) | 1 (4%) | | | Cervical intraepithelial neoplasia | 1 (4%) | 0 (0%) | | | Ovarian teratomas | 0 (0%) | 1 (4%) | | | Duration of pneumoperitoneum (min) | 145 (128, 167) | 145 (130, 170) | 0.876 | | Duration of anesthesia (min) | 171 (160, 209) | 180 (162, 199) | 0.884 | | Recovery time (min) | 20 (15, 26) | 20 (15, 28) | 0.914 | | Extubation time (min) | 20 (15, 24) | 20 (15, 25) | 0.692 | | Total fluid intake (ml) | 1500 (1500, 1600) | 1500 (1425, 1800) | 0.705 | | Bleeding volume (ml) | 100 (80, 120) | 100 (100, 175) | 0.477 | | Urine volume (ml) | 350 (275, 450) | 300 (250, 425) | 0.465 |
|
|
